Showing 1 - 8 results of 8 for search '"horsepox"', query time: 0.27s Refine Results
  1. 1
    A Holistic Assessment of the Risks and Benefits of the Synthesis of Horsepox Virus

    A Holistic Assessment of the Risks and Benefits of the Synthesis of Horsepox Virus by Diane DiEuliis, Gigi Kwik Gronvall

    Published 2018-04-01
    Subjects:
    Get full text
    Article
  2. 2
    Single Dose of Recombinant Chimeric Horsepox Virus (TNX-801) Vaccination Protects Macaques from Lethal Monkeypox Challenge

    Single Dose of Recombinant Chimeric Horsepox Virus (TNX-801) Vaccination Protects Macaques from Lethal Monkeypox Challenge by Ryan S. Noyce, Landon W. Westfall, Siobhan Fogarty, Karen Gilbert, Onesmo Mpanju, Helen Stillwell, José Esparza, Bruce Daugherty, Fusataka Koide, David H. Evans, Seth Lederman

    Published 2023-01-01
    Subjects: “…horsepox…”
    Get full text
    Article
  3. 3
    Recombinant chimeric horsepox virus (TNX-801) is attenuated relative to vaccinia virus strains in both in vitro and in vivo models

    Recombinant chimeric horsepox virus (TNX-801) is attenuated relative to vaccinia virus strains in both in vitro and in vivo models by Stephanie V. Trefry, Mayanka Awasthi, Christy N. Raney, Amy L. Cregger, Chase A. Gonzales, Brittney L. Layton, Robert N. Enamorado, Nelson A. Martinez, Deborah S. Gohegan, Masoudeh Masoud-Bahnamiri, Jennifer Y. Cho, Dawn M. Myscofski, Tinoush Moulaei, Natasza E. Ziółkowska, Scott J. Goebel, Seth Lederman, Sina Bavari, Farooq Nasar

    Published 2024-12-01
    Subjects:
    Get full text
    Article
  4. 4
    A Critical Analysis of the Scientific and Commercial Rationales for the <italic toggle="yes">De Novo</italic> Synthesis of Horsepox Virus

    A Critical Analysis of the Scientific and Commercial Rationales for the <italic toggle="yes">De Novo</italic> Synthesis of Horsepox Virus by Gregory D. Koblentz

    Published 2018-04-01
    Subjects:
    Get full text
    Article
  5. 5
    Immunogenicity and Tolerability of a SARS-CoV-2 TNX-1800, a Live Recombinant Poxvirus Vaccine Candidate, in Syrian Hamsters and New Zealand White Rabbits

    Immunogenicity and Tolerability of a SARS-CoV-2 TNX-1800, a Live Recombinant Poxvirus Vaccine Candidate, in Syrian Hamsters and New Zealand White Rabbits by Mayanka Awasthi, Anthony Macaluso, Scott J. Goebel, Erin Luea, Ryan S. Noyce, Farooq Nasar, Bruce Daugherty, Sina Bavari, Seth Lederman

    Published 2023-10-01
    Subjects:
    Get full text
    Article
  6. 6
    Immunogenicity and Efficacy of TNX-1800, A Live Virus Recombinant Poxvirus Vaccine Candidate, against SARS-CoV-2 Challenge in Nonhuman Primates

    Immunogenicity and Efficacy of TNX-1800, A Live Virus Recombinant Poxvirus Vaccine Candidate, against SARS-CoV-2 Challenge in Nonhuman Primates by Mayanka Awasthi, Anthony Macaluso, Dawn Myscofski, Jon Prigge, Fusataka Koide, Ryan S. Noyce, Siobhan Fogarty, Helen Stillwell, Scott J. Goebel, Bruce Daugherty, Farooq Nasar, Sina Bavari, Seth Lederman

    Published 2023-11-01
    Subjects:
    Get full text
    Article
  7. 7
    Comparative Pathology of Zoonotic Orthopoxviruses

    Comparative Pathology of Zoonotic Orthopoxviruses by Amy L. MacNeill

    Published 2022-08-01
    Subjects:
    Get full text
    Article
  8. 8
    Epidemiology of Horsepox. The New Aspects

    Epidemiology of Horsepox. The New Aspects by L. F. Stovba, A. A. Petrov, S. A. Melnikov, O. V. Chukhralia, N. K. Cherniкova, S. V. Borisevich

    Published 2024-09-01
    Subjects:
    Get full text
    Article

Search Tools: